Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance
European Journal of Pharmaceutical Sciences · 2024-12 · 203 · 106938
DOI: 10.1016/j.ejps.2024.106938 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Pharmaceutical Sciences, 2024-12. Verfasst von Kampanart Huanbutta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Manufacturing Pharmacy, College of Pharmacy, Rangsit University, Pathum Thani 12000, Thailand. Hauptthemen laut MEDLINE: Artificial Intelligence, Quality Control, Drug Industry, Drug Discovery. Die Arbeit wurde bisher 167-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Manufacturing Pharmacy, College of Pharmacy, Rangsit University, Pathum Thani 12000, Thailand.
- Thammasat University Research Unit in Smart Materials and Innovative Technology for Pharmaceutical Applications (SMIT-Pharm), Faculty of Pharmacy, Thammasat University, Pathumthani 12120, Thailand.
- Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, 73000, Thailand; Academy of Science, The Royal Society of Thailand, Bangkok, 10300, Thailand.
- Applied Computer Science Program, King Mongkut's University of Technology Thonburi, Bangkok, 10140, Thailand.
- Faculty of Pharmaceutical Sciences, Burapha University, 169, Seansook, Muang, Chonburi, 20131, Thailand.
- Faculty of Pharmaceutical Sciences, Burapha University, 169, Seansook, Muang, Chonburi, 20131, Thailand. Electronic address: tanikan@go.buu.ac.th.
Zitieren
APA
Huanbutta, K., Burapapadh, K., Kraisit, P., Sriamornsak, P., Ganokratanaa, T., Suwanpitak, K., & Sangnim, T. (2024). Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance. European Journal of Pharmaceutical Sciences, 203, 106938. https://doi.org/10.1016/j.ejps.2024.106938
Vancouver
Huanbutta K, Burapapadh K, Kraisit P, Sriamornsak P, Ganokratanaa T, Suwanpitak K, et al. Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance. European Journal of Pharmaceutical Sciences. 2024;203:106938. doi:10.1016/j.ejps.2024.106938
BibTeX
@article{Huanbutta2024,
author = {Huanbutta, Kampanart and Burapapadh, Kanokporn and Kraisit, Pakorn and Sriamornsak, Pornsak and Ganokratanaa, Thittaporn and Suwanpitak, Kittipat and Sangnim, Tanikan},
title = {Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance},
journal = {European Journal of Pharmaceutical Sciences},
year = {2024},
volume = {203},
pages = {106938},
doi = {10.1016/j.ejps.2024.106938}
}
EUVIMED